Detalhe da pesquisa
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055253
2.
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
Int J Gynecol Cancer
; 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38858106
3.
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
J Transl Med
; 21(1): 408, 2023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353806
4.
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
BMC Cancer
; 23(1): 393, 2023 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131154
5.
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.
Future Oncol
; 19(25): 1709-1714, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381977
6.
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse.
Int J Gynecol Cancer
; 33(4): 577-584, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631150
7.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183733
8.
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort.
Gynecol Oncol
; 167(1): 11-21, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970603
9.
The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
Gynecol Oncol
; 161(1): 166-172, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563488
10.
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
Gynecol Oncol
; 163(1): 64-71, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294414
11.
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.
Future Oncol
; 17(29): 3781-3785, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427115
12.
Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
Gynecol Oncol
; 157(1): 29-35, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241341
13.
Prediction of early discharge after gynaecological oncology surgery within ERAS.
Surg Endosc
; 34(5): 1985-1993, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309314
14.
Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.
Br J Clin Pharmacol
; 85(2): 403-412, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30394581
15.
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.
Breast Cancer Res Treat
; 162(2): 307-316, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28155054
16.
Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
Radiology
; 284(2): 432-442, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28301309
17.
Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.
Int J Gynecol Cancer
; 25(5): 815-22, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25768081
18.
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.
Mol Cancer
; 13: 228, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25277734
19.
The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know?
Cancers (Basel)
; 16(10)2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791919
20.
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.
Bull Cancer
; 110(10): 1041-1050, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659907